However, the recent Dengue Situation Update #720 issued by the WHO on April 3, 2025, indicates a concerning escalation in dengue cases. Over the past two weeks alone, Fiji reported more than 800 new dengue infections weekly, significantly surpassing the country’s typical five-year median of approximately 300 monthly cases during similar periods.
CDC Issues Travel Advisory for Fiji
In response to this developing public health situation, the United States Centers for Disease Control and Prevention (CDC) included Fiji in its revised Global Dengue Travel Health Advisory. This advisory urges travelers to exercise increased caution and take necessary precautions against mosquito bites to mitigate the risk of contracting the virus. The advisory, prominently displayed on the official CDC travel health website, provides essential guidelines for travelers on preventive measures such as using insect repellent, wearing long-sleeved clothing, and staying in accommodations equipped with adequate mosquito protection.
Potential Impacts on Fiji’s Tourism Sector
Tourism is a critical pillar of Fiji’s economy, significantly contributing to employment and GDP growth. The ongoing dengue outbreak may pose challenges for the tourism sector, as travelers reassess their vacation plans due to health and safety concerns. Official tourism boards and industry stakeholders are closely monitoring the situation, aware of potential cancellations or postponements of travel to the island nation.
However, Fiji’s tourism industry remains resilient, with stakeholders proactively disseminating information and implementing enhanced mosquito control and public health measures across resorts and tourist areas. According to the Fiji Ministry of Health and Medical Services website, comprehensive strategies are in place to manage dengue effectively, including public awareness campaigns, vector control initiatives, and strengthened healthcare infrastructure.
Vaccination and Prevention Efforts
Globally, around 40 countries have authorized the use of the second-generation dengue vaccine, QDENGA®, following recommendations issued by WHO’s Strategic Advisory Group of Experts on Immunization in October 2023. This vaccine offers promising potential in controlling dengue outbreaks. However, it remains unauthorized in the United States, limiting vaccine availability for American tourists traveling abroad.
Tourism Sector Resilience
Despite the dengue outbreak, tourism professionals remain optimistic about Fiji’s continued appeal as a top travel destination. Robust public health strategies, transparent communication, and stringent safety protocols reassure travelers, preserving Fiji’s reputation as a safe and welcoming destination.
Ultimately, ongoing collaboration between government authorities, health agencies, and the tourism industry will play a pivotal role in managing the dengue outbreak’s potential impacts. Fiji remains committed to safeguarding visitors while maintaining its position as one of the South Pacific’s premier travel locations.
Tags: WHO’s Strategic Advisory Group, vaccine, Fiji’s tourism industry, Fiji
